article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

(Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The full presentation is available at: [link]. Highlights from the presentation include: Declining PSA levels in treated patients.

Data 100
article thumbnail

Press Release: Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology

Cannabis Law Report

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

Cannabis Law Report

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. During this presentation, Chris Chapman, M.D., Wainwright 23rd Annual Global Investment Conference being held virtually September 13-15, 2021.

article thumbnail

Clinical Trial Finds Marijuana Oil to be Effective in Treating Fibromyalgia

The Joint Blog

Methods: A double-blind, randomized, placebo-controlled clinical trial was conducted for eight weeks to determine the benefit of a THC-rich cannabis oil (24.44 The placebo group presented significant improvement on the “depression” score after intervention. mg/mL of THC and 0.51 P < 0.001).

article thumbnail

Defined Research To Present Results From Pioneering CBD Clinical Trial For Insomnia At Sleep 2023 Medical Conference

Medical Marijuana Program Connection

a science-based wellness company announces the results of its clinical trial for Defined Sleep, a. SAN FRANCISCO–(BUSINESS WIRE)–Defined Research, Inc., Read More

article thumbnail

European Regulatory Lead MAPS PBC Santa Cruz, CA

Cannabis Law Report

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.

article thumbnail

Anebulo Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

Cannabis Law Report

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that management will present a company overview at the H.C. A webcast of the presentation will be available on-demand beginning January 10, 2022 at 7:00 a.m.